DFE Pharma
Ross Blezard has extensive experience in product application and formulation development within the pharmaceutical and biopharmaceutical sectors. Currently serving as a Product Application Specialist at DFE Pharma since February 2019, Ross also specializes in dry powder inhalers. Prior roles include Senior Scientist II positions at both Mondelēz International and Reading Scientific Services Ltd from June 2013 to February 2019, and as Head of Formulation Development at MedPharm Ltd from January 2010 to June 2013, focusing on inhalation and semi-solid products through to phase II clinical trials. Earlier experience includes work as a Junior Researcher at The Home Office, where Ross contributed to database development and FEA modeling. Educational qualifications include a Bachelor of Science (BSc) in Physics from the University of Surrey, completed in 2009. Proficient in programming languages such as C++, FORTRAN, and SQL, Ross possesses a solid foundation in fluid dynamics and health and safety regulations.
This person is not in any offices
DFE Pharma
2 followers
DFE Pharma is a global leader in pharmaceutical excipient solutions. We develop, produce and supply the highest quality functional excipients for use in the pharmaceutical, biopharmaceutical and nutraceutical industries for respiratory, oral solid dose (OSD), ophthalmic and parenteral formulations. Our excipients play an essential role as fillers, binders, disintegrants, and in stabilizing active ingredients for release in a predictable and effective manner into the patient’s system. With over a century of experience and over 400+ people worldwide in over 100 countries serving over 5,000 customers, DFE Pharma is committed to supporting (bio)pharmaceutical and nutraceutical companies in their journey to improve patients’ lives. We are driven by our purpose your medicines, our solutions. Moving to a healthier world. Learn more at www.dfepharma.com